IDR 57.0
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 75.23 Billion IDR | 3.79% |
2022 | 72.3 Billion IDR | -14.01% |
2021 | 84.08 Billion IDR | 94.81% |
2020 | 43.16 Billion IDR | 13.79% |
2019 | 37.93 Billion IDR | -14.89% |
2018 | 44.57 Billion IDR | 105.67% |
2017 | 21.67 Billion IDR | 45.24% |
2016 | 14.92 Billion IDR | 42.63% |
2015 | 10.46 Billion IDR | 30.49% |
2014 | 8.01 Billion IDR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 22.43 Billion IDR | 16.95% |
2024 Q3 | 21.08 Billion IDR | -6.0% |
2024 Q1 | 19.18 Billion IDR | -15.03% |
2023 Q4 | 22.57 Billion IDR | 23.08% |
2023 FY | 75.04 Billion IDR | 3.79% |
2023 Q1 | 19.77 Billion IDR | 8.94% |
2023 Q3 | 18.34 Billion IDR | -3.65% |
2023 Q2 | 19.03 Billion IDR | -3.73% |
2022 Q1 | 18.18 Billion IDR | -35.83% |
2022 Q3 | 17.86 Billion IDR | -1.36% |
2022 Q4 | 18.14 Billion IDR | 1.59% |
2022 FY | 72.3 Billion IDR | -14.01% |
2022 Q2 | 18.11 Billion IDR | -0.4% |
2021 FY | 84.08 Billion IDR | 94.81% |
2021 Q1 | 13.97 Billion IDR | 135.38% |
2021 Q2 | 19.36 Billion IDR | 38.55% |
2021 Q3 | 22.41 Billion IDR | 15.79% |
2021 Q4 | 28.33 Billion IDR | 26.39% |
2020 Q3 | 13.75 Billion IDR | 17.36% |
2020 Q2 | 11.71 Billion IDR | -0.35% |
2020 Q1 | 11.75 Billion IDR | 3991.84% |
2020 FY | 43.16 Billion IDR | 13.79% |
2020 Q4 | 5.93 Billion IDR | -56.83% |
2019 Q1 | 10.56 Billion IDR | 4.34% |
2019 FY | 37.93 Billion IDR | -14.89% |
2019 Q4 | -302.12 Million IDR | -102.1% |
2019 Q3 | 14.38 Billion IDR | 8.34% |
2019 Q2 | 13.28 Billion IDR | 25.7% |
2018 FY | 44.57 Billion IDR | 105.67% |
2018 Q1 | 11.04 Billion IDR | 2762.18% |
2018 Q2 | 9.13 Billion IDR | -17.27% |
2018 Q3 | 14.25 Billion IDR | 56.02% |
2018 Q4 | 10.12 Billion IDR | -28.99% |
2017 Q1 | 6.57 Billion IDR | 0.0% |
2017 Q4 | 385.96 Million IDR | -95.15% |
2017 Q2 | 6.57 Billion IDR | 0.0% |
2017 Q3 | 7.95 Billion IDR | 20.97% |
2017 FY | 21.67 Billion IDR | 45.24% |
2016 FY | 14.92 Billion IDR | 42.63% |
2015 FY | 10.46 Billion IDR | 30.49% |
2014 FY | 8.01 Billion IDR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
PT Bundamedik Tbk | 463.16 Billion IDR | 83.756% |
PT Metro Healthcare Indonesia Tbk | 125.19 Billion IDR | 39.904% |
PT Medikaloka Hermina Tbk | 1043.54 Billion IDR | 92.79% |
PT Mitra Keluarga Karyasehat Tbk | 783.59 Billion IDR | 90.399% |
PT Murni Sadar Tbk | 224.61 Billion IDR | 66.504% |
PT Famon Awal Bros Sedaya Tbk | 293.68 Billion IDR | 74.382% |
PT Kedoya Adyaraya Tbk | 105.27 Billion IDR | 28.53% |
PT Sarana Meditama Metropolitan Tbk | 393.56 Billion IDR | 80.883% |
PT Siloam International Hospitals Tbk | 2519.46 Billion IDR | 97.014% |
PT Sejahteraraya Anugrahjaya Tbk | 583.07 Billion IDR | 87.097% |